Notes
Journal of Natural Products, 2009, Vol. 72, No. 7 1367
again by Sephadex LH-20 CC using CH3OH as eluent. Further
purification of the subfractions by RP HPLC (40% CH3CN in H2O for
5 min, followed by 40-60% CH3CN in H2O for 25 min) afforded
cycloaspeptide F (1; 4.0 mg, tR 12.5 min).
changed to fresh DMEM. MTT (Sigma) was dissolved in serum-free
medium or PBS at 0.5 mg/mL and sonicated briefly. In the dark, 50
µL of MTT/medium was added into each well after the medium was
removed from wells and incubated at 37 °C for 3 h. Upon removal of
MTT/medium, 100 µL of DMSO was added to each well and shaken
at 60 rpm for 5 min to dissolve the precipitate. The assay plate was
read at 540 nm using a microplate reader.
Cycloaspeptide F (1): white powder; [R]D -18 (c 0.4, CH3OH); UV
(CH3OH) λmax (ε) 211 (100 100), 253 (17 600) nm; IR (neat) νmax 3323
1
(br), 2929, 2868, 1682, 1637, 1444, 1228, 1177, 1075 cm-1; H, 13C
NMR, and HMBC data see Table 1; NOESY correlations (acetone-d6,
600 MHz) H-18 T H-28; H3-10 T H-2, H-12; H3-15 T H-8, H-9;
Acknowledgment. We gratefully acknowledge financial support
from the Ministry of Science and Technology of China (2007AA021506
and 2009CB522302), the Chinese Academy of Sciences (KSCX2-YW-
G-013), and the National Natural Science Foundation of China
(30870057).
H3-29
T H-24, H-25; HRESIMS m/z 826.3634 (calcd for
C42H53N5O11Na, 826.3659).
Cycloaspeptide G (2): white powder; [R]D -16 (c 0.3, CH3OH);
λmax (ε) 211 (9000), 251 (12 500) nm; IR (neat) νmax 3303 (br), 2926,
2853, 1653, 1627, 1516, 1446, 1260, 1172, 1097 cm-1; 1H, 13C NMR,
and HMBC data see Table 2; NOESY correlations (acetone-d6, 600
MHz) H-18 T H-28; H3-10 T H-2, H-12; H3-15 T H-8, H-9; H3-29
T H-24, H-25; HRESIMS m/z 680.3047 (calcd for C36H43N5O7Na,
680.3055).
Supporting Information Available: 1H, 13C, and 2D NMR spectra
of cycloaspeptides F (1) and G (2). This material is available free of
Cycloaspeptide A (3): 1H, 13C NMR, and ESIMS data were consistent
with literature values.8
References and Notes
Cycloaspeptide C (4): 1H, 13C NMR, and ESIMS data were consistent
with literature values.8
(1) Chen, Y. Q.; Wang, N.; Qu, L. H.; Li, T. H.; Zhang, W. M. Biochem.
Syst. Ecol. 2001, 29, 597–607.
(2) Zhu, J. S.; Halpen, G. M.; Jones, K. J. Altern. Complement. Med.
1998, 4, 289–303.
(3) Gloer, J. B. Applications of Fungal Ecology in the Search of New
Bioactive Natural Products. In The Mycota IV: EnVironmental and
Microbial Relationships; Wicklow, D. T., Soderstrom, B., Eds.;
Springer-Verlag: Berlin, 1997; pp 249-268.
(4) Guo, H.; Hu, H.; Liu, S.; Liu, X.; Zhou, Y.; Che, Y. J. Nat. Prod.
2007, 70, 1519–1521.
(5) Zhang, Y.; Liu, S.; Liu, X.; Che, Y. J. Nat. Prod. 2007, 70, 1522–
1525.
(6) Che, Y.; Guo, H.; Du, Z.; Liu, X.; Ye, X.; Che, Y. Cell Prolif.,
accepted.
(7) Paterson, R. R. Phytochemistry 2008, 69, 1469–1495.
(8) Kobayashi, R.; Samejima, Y.; Nakajima, S.; Kawai, K.; Udagawa, S.
Chem. Pharm. Bull. 1987, 35, 1347–1352.
(9) Dalsgaard, P. W.; Larsen, T. O.; Frydenvang, K.; Christophersen, C.
J. Nat. Prod. 2004, 67, 878–881.
(10) DeVault, R. L.; Rosenbrook, W., Jr. J. Antibiot. 1973, 26, 532–534.
(11) Isaka, M.; Palasarn, S.; Rachtawee, P.; Vimuttipong, S.; Kongsaeree,
P. Org. Lett. 2005, 7, 2257–2260.
(12) Marfey, P. Carlsberg Res. Commun. 1984, 49, 591–596.
(13) Deyrup, S. T.; Gloer, J. B.; O’Donnell, K.; Wicklow, D. T. J. Nat.
Prod. 2007, 70, 378–382.
(14) Haddad, M.; Miyamoto, T.; Laurens, V.; Lacaille-Dubois, M. A. J.
Nat. Prod. 2003, 66, 372–377.
(15) Lewer, P.; Graupner, P. R.; Hahn, D. R.; Karr, L. L.; Duebelbeis,
D. O.; Anzeveno, P. B.; Fields, S. C.; Gilbert, J. R.; Pearce, C. J.
Nat. Prod. 2006, 69, 1506–1510.
(16) Jackson, M. A.; Cliquet, S.; Iten, L. B. Biocontrol Sci. Technol. 2003,
13, 23–33.
(17) Jackson, M. A.; McGuire, M. R.; Lacey, L. A.; Wraight, S. P. Mycol.
Res. 1997, 101, 35–41.
(18) Vidal, C.; Fargues, J.; Lacey, L. A.; Jackson, M. A. Mycopathologia
1998, 143, 33–46.
(19) Jiang, Y.; Jiang, X.; Wang, P.; Hu, X. J. Food Biochem. 2005, 29,
323–335.
Bisdethiodi(methylthio)hyalodendrin (5): 1H, 13C NMR, and ESIMS
data were consistent with literature values.10,11
Absolute Configuration of Ala and Leu in 1.12 Separate solutions
of cycloaspeptide F (1; 0.5 mg) and G (2; 0.5 mg) in 6 N HCl (1.0
mL) were heated at 155 °C for 1 h. Upon removal of excess HCl under
vacuum, the hydrolysate was placed in a 1 mL reaction vial and treated
with a 1% solution of FDAA (200 µL) in acetone, followed by 1.0 N
NaHCO3 (40 µL). The reaction mixtures were heated at 45 °C for 1.5 h,
cooled to room temperature, and then acidified with 2.0 N HCl (20
µL). In a similar fashion, standard L-Leu, D-Leu, L-Ala, and D-Ala were
derivatized separately. The derivatives of the acid hydrolysate and the
standard amino acids were subjected to RP HPLC analysis (Kromasil
C18 column; 10 µm, 4.6 × 250 mm; 2.0 mL/min) at 25 °C using the
following gradient program: solvent A, H2O (0.1% TFA); solvent B,
acetonitrile; linear gradient, 10-50% of B for 40 min with UV detection
at 340 nm. The retention times for the FDAA derivatives of L-Ala,
D-Ala, L-Leu, and D-Leu were 22.37, 23.94, 31.74, and 35.49 min,
respectively, whereas those for the FDAA derivatives of Ala and Leu
in the hydrolysate of 1 were 22.43 and 31.74 min, respectively.
Determination of D-Glc.13,14 A sample of 2.5 mg of cycloaspeptide
F (1) in 300 µL of acetone was added to 700 µL of 6 N HCl in a
hydrolysis tube and heated at 100 °C for 24 h. After evaporation of
excess CH3OH, 1.0 mg of L-cysteine methyl ester hydrochloride in
100 µL of pyridine was added, and the mixture was stirred at 60 °C
for 1 h. A 3:1 mixture of HMDS-TMCS (hexamethyldisilazane-tri-
methylchlorosilane) was then added (150 µL), and the solution was
stirred at 60 °C for another 30 min. The precipitate was centrifuged
off, and the supernatant was concentrated under a stream of N2. The
residue was partitioned between n-hexanes and H2O, and the hexane
layer was directly subjected to GC-MS analysis. The resulting Glc
derivative coeluted with a derivatized D-Glc standard (tR 19.04 min),
but not with a derivatized L-Glc standard (tR 19.25 min).
MTT Assay.4 In 96-well plates, each well was plated with 104 cells.
After cell attachment overnight, the medium was removed, and each
well was treated with 50 µL of medium containing 0.2% DMSO or
appropriate concentration of test compounds (10 mg/mL as stock
solution of a compound in DMSO and serial dilutions). Cells were
treated at 37 °C for 4 h in a humidified incubator at 5% CO2 first and
then were allowed to grow for another 48 h after the medium was
(20) Mori, Y.; Tsuboi, M.; Suzuki, M.; Fukushima, K.; Arai, T. J. Chem.
Soc., Chem. Commun. 1982, 94–96.
(21) Yamashita, Y.; Saitoh, Y.; Ando, K.; Takahashi, K.; Ohno, H.; Nakano,
H. J. Antibiot. 1990, 43, 1344–1346.
(22) Lang, G.; Blunt, J. W.; Cummings, N. J.; Cole, A. L.; Munro, M. H.
J. Nat. Prod. 2005, 68, 810–811.
NP900205M